HIV TREATMENT
2020
Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
2018 TREATMENT
Action 9 - WHO
Action 2 - EMA
Action 10 - WHO
Action 3 - EMA
Action 4 - EMA
Action 5 - USFDA
Action 6 - USFDA
Action 7 - USFDA
Action 11 - WHO
Action 12 - WHO
Action 13 - Pharma
Action 14 - Pharma
Action 8 - USFDA
Action 15 - Pharma
Action 18 - GAP-f
Action 22 - Donors
Action 30 - GAP-f
Action 24 - Pharma
Action 25 - Pharma
Action 26 - Pharma
Action 27 - Pharma
Action 28 -
Action 29 - GAP-f
Action 31 - GAP-f